Lv35
278 积分 2023-01-10 加入
Odronextamab: First Approval
29天前
已完结
An evaluation of odronextamab for the treatment of multiple subtypes of relapsed/refractory B-cell non-Hodgkin lymphoma
29天前
已完结
Odronextamab against relapsed or refractory follicular lymphoma
29天前
已关闭